HomeTagsRemeGen

RemeGen

Biotechnology

RemeGen’s RC118 for Injection Targeting Claudin 18.2 in Patients with Gastric and Pancreatic Cancers Granted Two Orphan Drug Designations by U.S. FDA

PR Newswire - December 13, 2022

RemeGen Co., Ltd. , a commercial-stage biotechnology company, announced on December 7, 2022, that its latest antibody-drug conjugate (ADC), RC118 for injection, has been granted...

Biotechnology

RemeGen’s Telitacicept and Disitamab Vedotin Enter China’s National Reimbursement Drug List for SLE and Gastric Cancer Treatment

PR Newswire - December 4, 2021

RemeGen Co., Ltd., a commercial-ready biotechnology company, announced that two of its innovative drugs, a dual-targeted TACI-Fc fusion protein, Telitacicept (RC18) for treating systemic...

Hot Topics

Read Magazine’s Weekly Roundup: Discover the Most Recent News Volvo Group, Owkin, Digital Wildcatters, GE HealthCare and More !

Wizz Air and Striim partnership will streamline mission-critical operations with real-time data pipelines

Digital Health Startup and Health Engagement Veteran, Linda Zespy, Joins CareHive as VP of Marketing and Engagement

Read Magazine’s Weekly Roundup: Discover the Most Recent News Volvo Group,…

Wizz Air and Striim partnership will streamline mission-critical operations with real-time…

Digital Health Startup and Health Engagement Veteran, Linda Zespy, Joins CareHive…

Cogent Biosciences Appoints Cole Pinnow as Chief Commercial Officer

RemeGen

Hot Topics

Read Magazine’s Weekly Roundup: Discover the Most Recent News Volvo Group, Owkin, Digital Wildcatters, GE HealthCare and More !

Wizz Air and Striim partnership will streamline mission-critical operations with real-time data pipelines

Digital Health Startup and Health Engagement Veteran, Linda Zespy, Joins CareHive as VP of Marketing and Engagement